Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

NCT00877799 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: CR845
DRUG: CR845
DRUG: CR845
DRUG: Placebo
DRUG: Placebo

Sponsor

Cara Therapeutics, Inc.